| Role |
Name |
Disclosure |
Details |
| Author | Harold J Farber, MD, Associate Professor, Department of Pediatrics, Section of Pulmonology, Baylor College of Medicine | Nothing to disclose | Details | | Coauthor | Nidhy S Paulose Varghese, MD, Postdoctoral Fellow, Department of Pediatrics, Section of Pulmonology, Baylor College of Medicine | Nothing to disclose | Details | | Coauthor | Bettina C Hilman, MD, Consulting Staff, The Asthma and Allergy Center | Nothing to disclose | Details | | Medical Editor | Girish D Sharma, MD, Associate Professor, Department of Pediatrics, Rush University Medical Center, Rush Children's Hospital; Director of Pediatric Pulmonary Section and Rush Cystic Fibrosis Center | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc | Pfizer Inc Avanir Pharma | Details | | Managing Editor | Charles Callahan, DO, Professor, Deputy Chief of Clinical Services, Walter Reed Army Medical Center | Nothing to disclose | Details | | CME Editor | Mary E Cataletto, MD, Associate Director, Division of Pediatric Pulmonology, Winthrop University Hospital; Associate Professor, Department of Clinical Pediatrics, State University of New York at Stony Brook | Nothing to disclose | Details | | Chief Editor | Michael R Bye, MD, Attending Physician, Pediatric Pulmonary Medicine, Columbia University Medical Center; Professor of Clinical Pediatrics, Division of Pulmonary Medicine, Columbia University College of Physicians and Surgeons | Merck | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Charles Callahan, Managing Editor |
The contributor discloses no conflict of interest. |
|